nach oben

Archives of Gynecology and Obstetrics

Erschienen in:

01.03.2010 | Reproductive Medicine

The effect of retrieved oocyte count on pregnancy outcomes in an assisted reproduction program

verfasst von: Tevfik Yoldemir, Ian S. Fraser

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Objective

To determine if women with less than five eggs retrieved do as well as women with more eggs retrieved in terms of pregnancy outcomes in our assisted reproduction program.

Method

Two hundred one women undergoing in vitro fertilization treatment at Fertility Unit in Royal Prince Alfred Hospital, University of Sydney, Australia were selected for retrospective evaluation. The women were grouped according to the number of oocytes retrieved at ovum pick-up. Group A consisted of women with less than 5 oocytes, group B with 5 to 10 oocytes and group C with 11 to 15 oocytes collected. Clinical and ongoing pregnancy rates were compared.

Results

There was no difference between the groups in terms of clinical and ongoing pregnancy rates.

Conclusion

With good IVF lab conditions, if a patient reaches embryo transfer, the number of eggs retrieved should not affect the likelihood of pregnancy outcome in an assisted reproductive technology treatment.

Fasouliotis SJ, Simon A, Laufer N (2000) Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet. J Assist Reprod Genet 17:357–373CrossRefPubMed

Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J (2003) Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update 9:61–76CrossRefPubMed

Surrey ES, Schoolcraft WB (2000) Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril 73:667–676CrossRefPubMed

Mahutte NG, Arici A (2002) Poor responders: does the protocol make a difference? Curr Opin Obstet Gynecol 14:275–281CrossRefPubMed

Serafini P, Stone B, Kerin J (1988) An alternative approach to controlled ovarian hyperstimulation in ‘poor responders’ with a gonadotrophin releasing hormone analog. Fertil Steril 49:90–95PubMed

Jenkins JM, Davies DW, Devonport H (1991) Comparison of ‘poor responders’ with ‘good responders’ using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilisation. Hum Reprod 6:918–921PubMed

Land J, Yarmolinskaya M, Dumoulin J, Evers J (1996) High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril 65:961–965PubMed

Raga F, Bonilla-Musoles F, Casan EM, Bonilla F (1999) Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol: improved reproductive outcome. Hum Reprod 14:1431–1434CrossRefPubMed

Surrey ES, Bower JA, Hill DM, Ramsey J, Surrey MW (1998) Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril 69:419–424CrossRefPubMed

10.

Fenichel P, Grimaldi M, Olivero JF (1989) Predictive value of hormone profiles before stimulation for in vitro fertilization. Fertil Steril 51:845–849PubMed

11.

Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD, te Velde ER (2002) Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril 77:328–336CrossRefPubMed

12.

Hendriks DJ, Mol BW, Bancsi LF, te Velde ER, Broekmans FJ (2005) Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil Steril 83:291–301CrossRefPubMed

13.

Mol BW, Verhagen TE, Hendriks DJ, Collins JA, Coomarasamy A, Opmeer BC (2006) Value of ovarian reserve testing before IVF: a clinical decision analysis. Hum Reprod 21:1816–1823CrossRefPubMed

14.

Farhi J, Homburg R, Ferber A (1997) Non-response to ovarian stimulation in normogonadotrophic, normogonadal women: a clinical sign of impending onset of ovarian failure pre-empting the rise in basal follicle stimulating hormone levels. Hum Reprod 12:241–243CrossRefPubMed

15.

Tanbo T, Dale PO, Lunde O (1992) Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulated follicle-stimulating hormone levels. Fertil Steril 57:819–824PubMed

16.

Winslow KL, Toner JP, Brzyski RG (1991) The gonadotrophin releasing hormone agonist stimulation test—a sensitive predictor of performance in the flare-up in vitro fertilization cycle. Fertil Steril 56:711–717PubMed

17.

Franchin R, De Ziegler D, Olivennes F (1994) Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting ‘poor responders’ in in vitro fertilization. Hum Reprod 9:1607–1611

18.

Smotrich DB, Widra EA, Gindoff PR (1995) Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertil Steril 64:1136–1140PubMed

19.

Lass A, Skull J, McVeigh E (1997) Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin for in-vitro fertilization can predict poor response. Hum Reprod 12:294–297CrossRefPubMed

20.

Tomas C, Nuojua-Huttunen S, Martikainen H (1997) Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization. Hum Reprod 12:220–223CrossRefPubMed

21.

Zaidi J, Barber J, Kyei-Mensah A (1996) Relationship of ovarian stromal blood flow at the baseline ultrasound scan to subsequent follicular response in an in vitro fertilization program. Obstet Gynecol 88:779–784CrossRefPubMed

22.

Klinkert ER, Broekmans FJ, Looman CW, te Velde ER (2004) A poor response in the first in vitro fertilization cycle is not necessarily related to a poor prognosis in subsequent cycles. Fertil Steril 81:1247–1253CrossRefPubMed

23.

Kailasam C, Keay SD, Wilson P, Ford WCL, Jenkins JM (2004) Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome. Hum Reprod 19:1544–1547CrossRefPubMed

24.

Templeton A, Morris JK, Parslow W (1996) Factors that affect outcome of in-vitro fertilisation treatment. Lancet 348:1402–1406CrossRefPubMed

25.

Tarin JJ, Sampaio MC, Calatayud C, Castellvi RM, Bonilla-Musoles F, Pellicer A (1992) Relativity of the concept ‘high responder to gonadotrophins’. Hum Reprod 7:19–22PubMed

26.

Devreker F, Pogonici E, De Maertelaer V, Revelard P, Van den Bergh M, Englert Y (1999) Selection of good embryos for transfer depends on embryo cohort size: implications for ‘mild ovarian stimulation’ debate. Hum Reprod 14:3002–3008CrossRefPubMed

27.

Gregory L (1998) Ovarian markers of implantation potential in assisted reproduction. Hum Reprod 13(Suppl 4):117–132PubMed

28.

Lashen H, Ledger W, Lopez-Bernal A, Barlow D (1999) Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile? Hum Reprod 14:964–969CrossRefPubMed

Titel: The effect of retrieved oocyte count on pregnancy outcomes in an assisted reproduction program
verfasst von: Tevfik Yoldemir
Ian S. Fraser
Publikationsdatum: 01.03.2010
Verlag: Springer-Verlag
Erschienen in: Archives of Gynecology and Obstetrics / Ausgabe 3/2010
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-009-1221-y

Neu im Fachgebiet Gynäkologie und Geburtshilfe

17.04.2024 | Postoperative nausea and vomiting | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

The effect of retrieved oocyte count on pregnancy outcomes in an assisted reproduction program

Abstract

Objective

Method

Results

Conclusion

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hochrisiko-Eingriffe für postoperative Übelkeit

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Update Gynäkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Objective

Method

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2010

Sleep–wake cycles in normal fetuses

Laparoscopic excision of a benign peritoneal cystic mesothelioma

Extraovarian primary peritoneal papillary serous carcinoma

Minilaparotomy in spinal anaesthesia: a surgical choice in treatment of benign gynaecologic disease

Intrauterine fetal bone retention after late-term abortion by external force in the 20th week of pregnancy

Sentinel lymph node biopsy in two Burgundy districts: prospective multicentric study on 528 breast cancers during the year 2005

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hochrisiko-Eingriffe für postoperative Übelkeit

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Update Gynäkologie